Miguel Tejada received a 105-game suspension from Major League baseball after testing positive for amphetamines for a second and third time this year. The suspension would run through the first 65 games of the 2014 season, which may simply push the 39-year-old Tejada into retirement instead.
On the heels of that news, Twins starter Mike Pelfrey talked with Mike Berardino of the St. Paul Pioneer Press about his own legal, by-the-book use of Adderall to treat his ADHD. You should read the whole article here, but here is an illuminating snippet:
“When I don’t take my Adderall, my mind, my thoughts are just all over the place,” he said. “When I’m taking it, I’m able to focus on one task and able to do one thing instead of (having) 20 different things pop in your head. It definitely helps.”
Without an attention deficit disorder or ADHD diagnosis, Adderall could give a player additional energy, Pelfrey said.
“When you don’t need it, it acts like a true amphetamine,” he said. “I don’t get all amped up on it. I’m probably more laid back when I’m on it. My thought process is toned down to one thing instead of 20 different things. Without it I’m pretty hyperactive and running around.”
Though it is easy to look at Pelfrey’s 5.26 ERA and snicker, it can be tough to muster the energy to play at peak athletic form on a day-in, day-out basis over a six-month span, which is why more and more players have been testing positive for amphetamine use in recent years rather than steroids.
Former Colorado Rockies outfielder Ryan Spilborghs wrote a column earlier this year suggesting that Major League Baseball could reduce the need for players to rely on performance-enhancing drugs by expanding rosters and putting a cap on the maximum amount of games in which a player can play. Of course, the issue is complex enough that a couple tweaks to the rules won’t fix the issue, but it does show that the onus is not just on the players.